Cargando...
Pharmacy Operationalization of the Intralesional Oncolytic Immunotherapy Talimogene Laherparepvec
Objective: Oncolytic immunotherapy involves the use of viruses to target and destroy cancer cells and to induce immune responses for an enhanced antitumor effect. Talimogene laherparepvec, a genetically modified herpes simplex virus type 1 (HSV-1) that selectively replicates in tumors to induce lyti...
Guardado en:
| Publicado en: | Hosp Pharm |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6130110/ https://ncbi.nlm.nih.gov/pubmed/30210146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578717749926 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|